A study just underway at UW Medicine is evaluating whether a lab-formulated monoclonal antibody could curb the over-amplified inflammatory response that some patients experience with COVID-19 pneumonia. The researchers are evaluating the drug's
The haze of wildfire smoke in the skies has become a common sight in late summer. Dr. Coralynn Sack, a UW Medicine pulmonologist, says her patients complain of worsened symptoms when smoke is in the air.
A risky surgical lung biopsy might not be needed to confirm idiopathic pulmonary fibrosis in patients suspected of having the deadly disorder, but whose lung scans don’t readily reveal a telltale honeycombing pattern.